EUVIMEDAtrasti EUVIMED
Crossref

Phosphodiesterase 5 inactivation in vascular smooth muscle cells aggravates aortic aneurysm and dissection

Yuyao Feng iD, Yunfei Xue, Xiaohang Feng, Zhiwei Li, Luxia Ren, Wenjun Guo, Yangfeng Hou, Ting Shu, Wensi Zhang, Yang Yang, Yitian Zhou, Kai Song and 4 more

The Journal of Pathology · 2025

DOI: 10.1002/path.6411 ↗

At a glance

Journal article in The Journal of Pathology, 2025. Written by Yuyao Feng and 15 co-authors. Institution: Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR Ch…. Major MEDLINE topics: Cyclic Nucleotide Phosphodiesterases, Type 5, Muscle, Smooth, Vascular, Aortic Dissection, Myocytes, Smooth Muscle. Cited 7 times so far (Crossref); 67 references. Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China, National High Level Hospital Clinical Research Funding.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Aortic aneurysm and dissection (AAD) are vascular disorders with high mortality. Previous evidence has suggested an elevated risk of AAD associated with the use of phosphodiesterase 5A (PDE5A) inhibitors. PDE5A, a cGMP‐hydrolyzing enzyme, is enriched in vascular smooth muscle cells (SMCs), but the role of SMC‐specific PDE5A in the pathogenesis of AAD is still unclear. In this study, PDE5A expression in human and mouse aortic tissues was analyzed by single‐cell RNA sequencing (scRNA‐seq), western blotting, immunofluorescence, and immunohistochemistry staining. SMC‐specific PDE5A knockout (PDE5A SMC−/− ) and PDE5A‐overexpressing (PDE5A SMC‐OE ) mice were constructed and utilized, along with an AAD mouse model induced by a high‐fat diet and angiotensin II (Ang II) infusion. In vivo imaging and histological analyses were performed to assess aortic pathologies. PDE5A expression was reduced in human and mouse AAD aortic tissues, primarily in SMCs. Pharmacological inhibition or genetic knockout of PDE5A in SMCs exacerbated aortic wall dilatation and elastin fiber degradation, increasing AAD incidence. In contrast, the AAD phenotype was rescued in challenged PDE5A SMC‐OE mice. Mechanistically, PDE5A expression influenced myosin light chain (MLC) phosphorylation, a key regulator of SMC contractility. In AAD tissues from PDE5A SMC−/− mice, increased cGMP‐dependent protein kinase (PKG) activation and decreased MLC phosphorylation indicate enhanced aortic relaxation. In conclusion, our findings suggest that PDE5A downregulation or inhibition plays a causative role in exacerbating AAD likely by potentiating cGMP/PKG‐mediated aortic SMC relaxation. Our findings highlight the need for caution in the clinical use of PDE5 inhibitors in patients at risk of aortic diseases. © 2025 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Cyclic Nucleotide Phosphodiesterases, Type 5Muscle, Smooth, VascularAortic DissectionMyocytes, Smooth MuscleAortic AneurysmPhosphodiesterase 5 InhibitorsAnimalsHumansMice, KnockoutMiceDisease Models, AnimalMaleMice, Inbred C57BLAngiotensin IIAortaFemale

Author keywords

PDE5 inhibitorPDE5APDE5A knockoutSMC contractibilityaortic aneurysmaortic dissectioncGMP pathwayside effectsildenafilsmooth muscle cell

Substances

Cyclic Nucleotide Phosphodiesterases, Type 5PDE5A protein, humanPde5a protein, mousePhosphodiesterase 5 InhibitorsAngiotensin II

Authors and institutions

  • Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China.
  • Department of Vascular Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, PR China.
  • Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, PR China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, PR China.
  • State Key Laboratory of Complex, Severe, and Rare Diseases, Beijing, PR China.

ORCID profiles: Yuyao Feng

Funding

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National High Level Hospital Clinical Research Funding

Cite

APA

Feng, Y., Xue, Y., Feng, X., Li, Z., Ren, L., Guo, W., Hou, Y., Shu, T., Zhang, W., Yang, Y., Zhou, Y., Song, K., Xiong, J., Liu, B., Wang, J., & Zhao, H. (2025). Phosphodiesterase 5 inactivation in vascular smooth muscle cells aggravates aortic aneurysm and dissection. The Journal of Pathology. https://doi.org/10.1002/path.6411

Vancouver

Feng Y, Xue Y, Feng X, Li Z, Ren L, Guo W, et al. Phosphodiesterase 5 inactivation in vascular smooth muscle cells aggravates aortic aneurysm and dissection. The Journal of Pathology. 2025. doi:10.1002/path.6411

BibTeX
@article{Feng2025,
  author = {Feng, Yuyao and Xue, Yunfei and Feng, Xiaohang and Li, Zhiwei and Ren, Luxia and Guo, Wenjun and Hou, Yangfeng and Shu, Ting and Zhang, Wensi and Yang, Yang and Zhou, Yitian and Song, Kai and Xiong, Jiang and Liu, Bao and Wang, Jing and Zhao, Hongmei},
  title = {Phosphodiesterase 5 inactivation in vascular smooth muscle cells aggravates aortic aneurysm and dissection},
  journal = {The Journal of Pathology},
  year = {2025},
  doi = {10.1002/path.6411}
}
Start for free →